Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.
Zhongzhi Pharmaceutical Dividend Announcement
• Zhongzhi Pharmaceutical announced a semi annually dividend of HK$0.03 per ordinary share which will be made payable on 2024-06-13. Ex dividend date: 2024-05-24
• Zhongzhi Pharmaceutical annual dividend for 2024 was HK$0.03
• Zhongzhi Pharmaceutical annual dividend for 2023 was HK$0.13
• Zhongzhi Pharmaceutical's trailing twelve-month (TTM) dividend yield is 3.72%
• Zhongzhi Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 62.69%
Zhongzhi Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-24 | HK$0.03 | semi annually | 2024-06-13 |
2023-10-17 | HK$0.06 | semi annually | 2023-11-02 |
2023-05-23 | HK$0.07 | semi annually | 2023-06-16 |
2020-10-15 | HK$0.05 | semi annually | 2020-11-02 |
2020-05-21 | HK$0.02 | semi annually | 2020-06-10 |
2019-10-15 | HK$0.03 | semi annually | 2019-11-01 |
2019-05-22 | HK$0.04 | semi annually | 2019-06-10 |
2018-10-16 | HK$0.02 | semi annually | 2018-11-20 |
2018-05-16 | HK$0.05 | semi annually | 2018-06-04 |
2017-10-17 | HK$0.02 | semi annually | 2017-11-15 |
2017-05-24 | HK$0.01 | semi annually | 2017-06-21 |
2016-10-05 | HK$0.02 | semi annually | |
2016-05-17 | HK$0.04 | semi annually | |
2016-05-10 | HK$0.04 | semi annually |
Zhongzhi Pharmaceutical Dividend per year
Zhongzhi Pharmaceutical Dividend growth
Zhongzhi Pharmaceutical Dividend Yield
Zhongzhi Pharmaceutical current trailing twelve-month (TTM) dividend yield is 3.72%. Interested in purchasing Zhongzhi Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Zhongzhi Pharmaceutical Financial Ratios
Zhongzhi Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Zhongzhi Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Zhongzhi Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Zhongzhi Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Zhongzhi Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Zhongzhi Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Zhongzhi Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Zhongzhi Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Zhongzhi Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Zhongzhi Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Zhongzhi Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Zhongzhi Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.